» Articles » PMID: 30948337

Surgical Management of the Placenta Accreta Spectrum: An Institutional Experience

Overview
Publisher Elsevier
Date 2019 Apr 6
PMID 30948337
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The incidence of placenta accreta spectrum (PAS) has risen over the past decades, primarily in response to increasing Caesarean section rates. The surgical management of PAS is associated with significant morbidity, including hemorrhage and intensive care unit (ICU) admission. This study sought to evaluate the surgical outcomes of a PAS operative approach.

Methods: A single-centre retrospective chart review of all Caesarean hysterectomies for PAS by an assigned surgeon over a 16-year period was performed. Surgical outcomes were described (Canadian Task Force Classification II-2).

Results: The described surgical approach involves a midline skin incision, high midline hysterotomy, a rapid single-layer uterine closure with no placental removal attempt, constant cephalad uterine traction, and liberal choice of subtotal hysterectomy. A total of 47 patients were included: 19 (40.4%) with placenta accreta, 14 (29.8%) with placenta increta, and 14 (29.8%) with placenta percreta. Mean estimated blood loss was 1416 ± 699 mL, and mean operative time was 112 ± 49 minutes. Overall, 16 patients (34.0%) required blood transfusion, and 4 patients (8.5%) required ICU admission. The average hospitalization was 5.2 days, with no re-admission within 30 days. The use of internal iliac balloons did not result in a difference in blood loss or operative time (P > 0.05). Patients with placenta percreta had significantly more blood loss (P = 0.02) and longer operative time (P = 0.007) compared with those with placenta accreta and increta.

Conclusion: The current surgical model for planned Caesarean hysterectomy for PAS exhibits a low complication rate. Further research is needed for developing a standardized approach to the management of PAS.

Citing Articles

Uterus-preserving surgical management of placenta accreta spectrum disorder: a large retrospective study.

Pan W, Chen J, Zou Y, Yang K, Liu Q, Sun M BMC Pregnancy Childbirth. 2023; 23(1):615.

PMID: 37633887 PMC: 10464453. DOI: 10.1186/s12884-023-05923-9.


Implementation and Outcomes of a Model of Care for Placenta Accreta Spectrum in a Community-Based Private Practice.

Wagner W, Loichinger M, Sidebottom A, Wunderlich W, Vacquier M, Jentink T Am J Perinatol. 2022; 41(8):1008-1018.

PMID: 35815573 PMC: 11105945. DOI: 10.1055/s-0042-1749664.


Treatment of Placenta Increta With High-Intensity Focused Ultrasound Ablation and Leaving the Placenta : A Multicenter Comparative Study.

Guan X, Huang X, Ye M, Huang G, Xiao X, Chen J Front Med (Lausanne). 2022; 9:871528.

PMID: 35463039 PMC: 9021530. DOI: 10.3389/fmed.2022.871528.


Maternal and neonatal outcomes in transverse and vertical skin incision for placenta previa : Skin incision for placenta previa.

Fan D, Zhang H, Rao J, Lin D, Wu S, Li P BMC Pregnancy Childbirth. 2021; 21(1):441.

PMID: 34167519 PMC: 8229347. DOI: 10.1186/s12884-021-03923-1.


Placenta accreta spectrum disorders-experience of management in a German tertiary perinatal centre.

Bluth A, Schindelhauer A, Nitzsche K, Wimberger P, Birdir C Arch Gynecol Obstet. 2020; 303(6):1451-1460.

PMID: 33284419 PMC: 8087589. DOI: 10.1007/s00404-020-05875-x.